SJ Medical
Uganda is currently undergoing a significant epidemiological shift. As urbanization and lifestyle changes accelerate in cities like Kampala and Entebbe, the prevalence of Peripheral Artery Disease (PAD) and Coronary Artery Disease (CAD) has seen a marked increase. For decades, traditional bypass surgeries were the only options; however, the Ugandan Ministry of Health and private healthcare providers are now prioritizing minimally invasive interventional radiology.
The demand for advanced Atherectomy Systems—devices designed to remove plaque from blood vessels rather than simply compressing it with balloons—is reaching a critical threshold. These systems are essential for treating complex calcified lesions that are frequently encountered in the aging Ugandan demographic and diabetic patient populations.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide, including specialized support for the African medical market.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
As a leading Atherectomy Systems Manufacturer, our facility in Hangzhou operates under Industry 4.0 principles. For Ugandan medical distributors, this means "Supply Chain Resilience"—the ability to maintain consistent stock of critical catheters and aspiration systems despite global logistical fluctuations.
Our 5,000-square-meter facility features:
Our technical team, led by senior engineers with decades of industry experience, maintains strict quality control, ensuring that every product reaching the East African market is a testament to precision engineering.
Navigating the regulatory environment in Uganda requires a partner who understands the National Drug Authority (NDA) requirements. We provide comprehensive documentation to facilitate the registration of vascular devices in Uganda, including:
We do not just sell products; we provide Integrated Vascular Solutions. For a new cardiac center in Kampala, we can supply everything from the initial diagnostic catheter sheath to the final therapeutic aspiration device.
Our global market reach—spanning Italy, India, and now the growing East African corridor—allows us to leverage economies of scale, providing Ugandan healthcare providers with "Premium Quality at Optimized Costs." This is essential for the sustainable growth of public healthcare under the Uganda National Health Insurance Scheme.
The next five years will see a digital revolution in Ugandan healthcare. SJ Medical is preparing for this by integrating AI-assisted navigation into our atherectomy systems. Our roadmap includes:
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We are committed to providing comprehensive and professional services throughout the entire customer journey, specifically tailored to the unique needs of the Ugandan market.